133 related articles for article (PubMed ID: 21703530)
1. γ-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure.
Ess M; Mussner-Seeber C; Mariacher S; Lorsbach-Koehler A; Pachinger O; Frick M; Ulmer H; Poelzl G
J Card Fail; 2011 Jul; 17(7):577-84. PubMed ID: 21703530
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
5. Serum phosphate and long-term outcome among patients with stable heart failure.
Ess M; Heitmair-Wietzorrek K; Frick M; Umlauf N; Ulmer H; Poelzl G
J Card Fail; 2013 Jan; 19(1):25-30. PubMed ID: 23273591
[TBL] [Abstract][Full Text] [Related]
6. β-blockers modify the prognostic value of adiponectin in chronic heart failure.
Van Berendoncks AM; Beckers P; Hoymans VY; Possemiers N; Coenen S; Elseviers MM; Vrints CJ; Conraads VM
Int J Cardiol; 2011 Aug; 150(3):296-300. PubMed ID: 20488568
[TBL] [Abstract][Full Text] [Related]
7. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
8. Serum cholestasis markers as predictors of early outcome after liver transplantation.
Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of biochemical liver parameters in neonatal sepsis-associated cholestasis.
Oswari H; Widjaja RK; Rohsiswatmo R; Cleghorn G
J Paediatr Child Health; 2013 Jan; 49(1):E6-11. PubMed ID: 23279060
[TBL] [Abstract][Full Text] [Related]
10. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?
Ulus T; Yildirir A; Sade LE; Temiz A; Polat E; Bozbaş H; Aydinalp A; Eroğlu S; Ozin B; Müderrisoğlu H
Coron Artery Dis; 2008 Nov; 19(7):489-95. PubMed ID: 18923245
[TBL] [Abstract][Full Text] [Related]
11. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease.
Emdin M; Passino C; Michelassi C; Donato L; Pompella A; Paolicchi A
Int J Cardiol; 2009 Jul; 136(1):80-5. PubMed ID: 18656271
[TBL] [Abstract][Full Text] [Related]
12. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10: an independent predictor of mortality in chronic heart failure.
Molyneux SL; Florkowski CM; George PM; Pilbrow AP; Frampton CM; Lever M; Richards AM
J Am Coll Cardiol; 2008 Oct; 52(18):1435-41. PubMed ID: 19017509
[TBL] [Abstract][Full Text] [Related]
15. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
17. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany.
Brenner H; Rothenbacher D; Arndt V; Schuberth S; Fraisse E; Fliedner TM
Prev Med; 1997; 26(3):305-10. PubMed ID: 9144754
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
[TBL] [Abstract][Full Text] [Related]
19. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification.
Perna ER; Macin SM; Canella JP; Augier N; Stival JL; Cialzeta JR; Pitzus AE; Garcia EH; Obregón R; Brizuela M; Barbagelata A
Circulation; 2004 Oct; 110(16):2376-82. PubMed ID: 15477403
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
